Genoskin Inc.

Salem,  MA 
United States
  • Booth: 1735

Early access to human data to de-risk drug development

Genoskin is a TechBio company that leverages immunology to de-risk drug and vaccine development, by enabling earlier access to human data. Our platform uses bio-stabilized and immunocompetent ex-vivo human skin to elucidate efficacy and toxicity of self-injected biotherapeutics. Combined with next-generation transcriptomics, multiplexed proteomics and artificial intelligence, we generate actionable human data, significantly reducing the costs, length and risks associated with drug development.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".